Correlation Between Kineta and Lumos Pharma
Can any of the company-specific risk be diversified away by investing in both Kineta and Lumos Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kineta and Lumos Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kineta Inc and Lumos Pharma, you can compare the effects of market volatilities on Kineta and Lumos Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kineta with a short position of Lumos Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kineta and Lumos Pharma.
Diversification Opportunities for Kineta and Lumos Pharma
-0.28 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Kineta and Lumos is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Kineta Inc and Lumos Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lumos Pharma and Kineta is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kineta Inc are associated (or correlated) with Lumos Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lumos Pharma has no effect on the direction of Kineta i.e., Kineta and Lumos Pharma go up and down completely randomly.
Pair Corralation between Kineta and Lumos Pharma
Allowing for the 90-day total investment horizon Kineta Inc is expected to under-perform the Lumos Pharma. In addition to that, Kineta is 4.08 times more volatile than Lumos Pharma. It trades about -0.53 of its total potential returns per unit of risk. Lumos Pharma is currently generating about -0.08 per unit of volatility. If you would invest 445.00 in Lumos Pharma on October 26, 2024 and sell it today you would lose (11.00) from holding Lumos Pharma or give up 2.47% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 57.58% |
Values | Daily Returns |
Kineta Inc vs. Lumos Pharma
Performance |
Timeline |
Kineta Inc |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Lumos Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Kineta and Lumos Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Kineta and Lumos Pharma
The main advantage of trading using opposite Kineta and Lumos Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kineta position performs unexpectedly, Lumos Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lumos Pharma will offset losses from the drop in Lumos Pharma's long position.Kineta vs. Rezolute | Kineta vs. XOMA Corporation | Kineta vs. Protagenic Therapeutics | Kineta vs. Tempest Therapeutics |
Lumos Pharma vs. Shattuck Labs | Lumos Pharma vs. Champions Oncology | Lumos Pharma vs. Century Therapeutics | Lumos Pharma vs. Silo Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |